ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Principal U.S. Small-Cap Multi-Factor ETF
47.51
+0.1200
0.25%
盘后:
47.51
0.0000
0.00%
16:05 EDT
成交量:
3.98万
成交额:
188.04万
市值:
7.27亿
市盈率:
52.79
高:
47.52
开:
47.22
低:
46.95
收:
47.39
数据加载中...
总览
公司
新闻
公告
新股消息 | 泽辉生物港股IPO招股书失效 致力于研发PSC的创新细胞治疗产品
智通财经
·
03-31
超100亿!这家油服公司连获重大合同
国际船舶网
·
03-30
高价收技术,持续巨亏!探秘天价股权激励背后的故事
星空财研
·
2024-11-07
前宣武医院主任携泽辉生物赴港IPO,中国科学院成“关键先生”
蓝鲸财经
·
2024-10-30
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PSC/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSC\",,,,,undefined,":{"symbol":"PSC","market":"US","secType":"STK","nameCN":"Principal U.S. Small-Cap Multi-Factor ETF","latestPrice":47.51,"timestamp":1745611200000,"preClose":47.39,"halted":0,"volume":39818,"hourTrading":{"tag":"盘后","latestPrice":47.51,"preClose":47.51,"latestTime":"16:05 EDT","volume":2,"amount":95.02,"timestamp":1745611512925},"delay":0,"floatShares":15300001,"shares":15300001,"eps":0.9,"marketStatus":"休市中","change":0.12,"latestTime":"04-25 16:00:00 EDT","open":47.22,"high":47.52,"low":46.95,"amount":1880381.339218,"amplitude":0.012028,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.9,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":47.39,"sharesOutstanding":15320001,"nav":46.559222,"aum":726797464.03,"dividendRate":0.008336,"bidAskSpread":0.002363,"postHourTrading":{"tag":"盘后","latestPrice":47.51,"preClose":47.51,"latestTime":"16:05 EDT","volume":2,"amount":95.02,"timestamp":1745611512925},"volumeRatio":0.251122},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PSC\",,,,,undefined,":{"symbol":"PSC","floatShares":15300001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.251122,"shares":15300001,"dividePrice":0.396028,"high":47.52,"amplitude":0.012028,"preClose":47.39,"low":46.95,"week52Low":42.36,"pbRate":"--","week52High":57.24,"institutionHeld":0,"latestPrice":47.51,"eps":0.9,"divideRate":0.008336,"volume":39818,"delay":0,"ttmEps":0.9,"open":47.22,"prevYearClose":51.27,"prevWeekClose":45.92,"prevMonthClose":48.5596,"prevQuarterClose":48.5596,"fiveDayClose":45.92,"twentyDayClose":49.1211,"sixtyDayClose":53.41},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PSC\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523567069","title":"新股消息 | 泽辉生物港股IPO招股书失效 致力于研发PSC的创新细胞治疗产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2523567069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523567069?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 11:18","pubTimestamp":1743391084,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,泽辉生物科技有限公司于2024年9月30日所递交的港股招股书满6个月,于2025年3月30日失效,递表时中金公司为其独家保荐人。招股书披露,泽辉生物是一家进入临床研发阶段的生物制药公司,自2017年成立以来,致力于开发治疗多种疾病的多能干细胞来源的创新细胞治疗产品。目前,公司的产品组合包括核心产品 ZH901以及主要产品ZH903、ZH902 及ZH906。公司的主要产品ZH906用于治疗角膜内皮失代偿,正处于临床前阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1271378.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4614","YANG","PSC","HSCEI","HSTECH"],"gpt_icon":1},{"id":"2523628772","title":"超100亿!这家油服公司连获重大合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2523628772","media":"国际船舶网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523628772?lang=zh_cn&edition=fundamental","pubTime":"2025-03-30 09:41","pubTimestamp":1743298886,"startTime":"0","endTime":"0","summary":"近日,油服供应商TechnipFMC宣布与壳牌巴西公司正式签署价值超过10亿美元的集成工程、采购、施工和安装总承包合同,涉及巴西近海Gato do Mato开发项目。其中BM-S-54区块于2005年签订特许经营合同,Sul de Gato do Mato区块于2017年签订产量分成合同。据了解,TechnipFMC在2017年由Technip和FMC Technologies合并而来,是一家完全整合的海底服务供应商。2021年,TechnipFMC分拆成为两家独立的上市公司TechnipFMC和Technip Energies。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250330124656a6a90bd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250330124656a6a90bd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTO","LU0300736492.USD","FID","LU0054578231.USD","FTI","LU0300736062.USD","PSC","LU0053671581.USD","BK4179","BK4160"],"gpt_icon":0},{"id":"2482460615","title":"高价收技术,持续巨亏!探秘天价股权激励背后的故事","url":"https://stock-news.laohu8.com/highlight/detail?id=2482460615","media":"星空财研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482460615?lang=zh_cn&edition=fundamental","pubTime":"2024-11-07 17:25","pubTimestamp":1730971523,"startTime":"0","endTime":"0","summary":"大家都知道,国内在生物医药领域和头部国家们还有较大的差距,不过近些年来在不少细分领域,国内企业奋起直追,在极个别领域中取得了先发优势。来自北京的泽辉生物科技有限公司(简称:泽辉生物)就是一家拥有一定....","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OnBtud3hHHSUJfUN3MzlzrCLwW7FdFS0pgqjVhJ3JyiQEAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241107A078B300","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241107A078B300","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["BK1161","BK4139","02257","ARDS","02197","PSC"],"gpt_icon":0},{"id":"2479833780","title":"前宣武医院主任携泽辉生物赴港IPO,中国科学院成“关键先生”","url":"https://stock-news.laohu8.com/highlight/detail?id=2479833780","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479833780?lang=zh_cn&edition=fundamental","pubTime":"2024-10-30 23:11","pubTimestamp":1730301095,"startTime":"0","endTime":"0","summary":"(图片来源:视觉中国)蓝鲸新闻10月30日讯(记者 邵雨婷)今年,干细胞市场风起云涌。日前,中国专家牵头制定了全球首个干细胞数据国际标准,中国首个干细胞创新药也申报上市,干细胞创新药有望在国内掀起商业化浪潮。2024年9月30日,专注研发干细胞创新药的泽辉生物科技有限公司(以下简称“泽辉生物”)向港交所递交招股...","market":"hk","thumbnail":"https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/Osr--0F7KMiVZqv7CmBLJoBcYpoOlRHAkY9X3uyNNV89sAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241030A0AGTX00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241030A0AGTX00","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["PSC"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PSC\",params:#limit:5,,,undefined,":[{"date":"2025-04-01","symbol":"PSC","amount":0.110318,"announcedDate":"2025-01-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-01","defaultRemindTime":1743514200000,"name":"Principal U.S. Small-Cap Multi-Factor ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-03","payableDate":"2025-04-01","currency":"USD","dateTimestamp":1743480000000,"payDate":"2025-04-03"},{"date":"2024-12-27","symbol":"PSC","amount":0.07952,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-27","defaultRemindTime":1735309800000,"name":"Principal U.S. Small-Cap Multi-Factor ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-31","payableDate":"2024-12-27","currency":"USD","dateTimestamp":1735275600000,"payDate":"2024-12-31"},{"date":"2024-10-01","symbol":"PSC","amount":0.1071,"announcedDate":"2024-09-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-01","defaultRemindTime":1727789400000,"name":"Principal U.S. Small-Cap Multi-Factor ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-03","payableDate":"2024-10-01","currency":"USD","dateTimestamp":1727755200000,"payDate":"2024-10-03"},{"date":"2024-07-01","symbol":"PSC","amount":0.09909,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-07-01","name":"Principal U.S. Small-Cap Multi-Factor ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-03","payableDate":"2024-07-01","currency":"USD","dateTimestamp":1719806400000,"payDate":"2024-07-03"},{"date":"2024-04-01","symbol":"PSC","amount":0.096411,"announcedDate":"2024-03-28","type":"dividend","market":"US","newRecordDate":"2024-04-02","defaultRemindTime":1711978200000,"name":"Principal U.S. Small-Cap Multi-Factor ETF","recordDate":"2024-04-04","payableDate":"2024-04-02","currency":"USD","dateTimestamp":1711944000000,"payDate":"2024-04-04"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PSC\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-04","value":0.0954808,"currency":"USD"},{"executeDate":"2017-04-03","recordDate":"2017-04-05","paymentDate":"2017-04-07","value":0.073752,"currency":"USD"},{"executeDate":"2017-07-03","recordDate":"2017-07-06","paymentDate":"2017-07-10","value":0.078723,"currency":"USD"},{"executeDate":"2017-10-02","recordDate":"2017-10-03","paymentDate":"2017-10-05","value":0.053592,"currency":"USD"},{"executeDate":"2018-04-02","recordDate":"2018-04-03","paymentDate":"2018-04-05","value":0.083439,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PSC\",market:\"US\",delay:false,,,undefined,":{}}}